Literature DB >> 31786802

A Kantian defence of placebo deception.

Anton Allen1,2,3.   

Abstract

In this article I offer a defence of the use of deceptive placebos-inert treatments like sugar pills or saline injections-in clinical practice. In particular, I will defend what I call the ideal placebo case-where a doctor or nurse has good reason to believe that a deceptive placebo offers a patient's best, or only, chance of some therapeutic benefit. Taking a Kantian approach to the question of clinical placebo use, I examine the Kantian prohibition on deception as interference with the will of a rational agent, and argue that deception to promote the placebo effect can be carried out in a way that does not interfere with the patient's will in the way prohibited by Kant. The deception involved in a placebo treatment is not carried out to interfere with or obstruct the function of the will, but merely to make possible a means to the patient's ends that that would otherwise be unavailable. I will therefore argue that deception carried out in order to promote a therapeutic placebo effect can be done in a way that is consistent with respect for a patient's autonomy, and may be a rare case of deception that is compatible with a Kantian ethical approach.

Entities:  

Keywords:  Autonomy; Deception; Ethics; Kant; Placebos

Mesh:

Substances:

Year:  2019        PMID: 31786802     DOI: 10.1007/s40592-019-00102-z

Source DB:  PubMed          Journal:  Monash Bioeth Rev        ISSN: 1321-2753


  3 in total

Review 1.  Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment.

Authors:  A Hróbjartsson; P C Gøtzsche
Journal:  N Engl J Med       Date:  2001-05-24       Impact factor: 91.245

2.  The moral case for the clinical placebo.

Authors:  Azgad Gold; Pesach Lichtenberg
Journal:  J Med Ethics       Date:  2013-06-08       Impact factor: 2.903

3.  Placebos without deception: a randomized controlled trial in irritable bowel syndrome.

Authors:  Ted J Kaptchuk; Elizabeth Friedlander; John M Kelley; M Norma Sanchez; Efi Kokkotou; Joyce P Singer; Magda Kowalczykowski; Franklin G Miller; Irving Kirsch; Anthony J Lembo
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.